## AI for Cancer Drug Industry

 
ChemicalQDevice innovates conversational AI applications regarding cancer drug clinical trial studies, clinical decision support, cancer signaling pathways, industry cost solutions, drug cost containment, bioprocess engineering, biosynthesis, characterization, and drug synthesis. 

OpenAI, Anthropic, Gemini, and xAI scalable direct chat proprietary software are utilized to generate LLM reports and propose detailed analysis. AI governance is employed with relevant software implementations, model bias amplification mitigation, and traceability analyses. 

  


[![DOI](https://zenodo.org/badge/DOI/10.5281/zenodo.13273141.svg)](https://doi.org/10.5281/zenodo.13273141)


